A shorter duration of CRS could be observed when treatment was given at a remarkably elevated IL-6 (median, 5; range, 3–13 days versus median, 8; range, 2–14 days, p=0.0575, Figure 4A), but without statistical difference. This evidence concerns the gene IL6 and congenital rubella syndrome.